Aljaberi, N; Tronconi, E; Schulert, G; Grom, AA; Lovell, DJ; Huggins, JL; Henrickson, M; Brunner, HI. The use of S100 proteins testing in juvenile idiopathic arthritis and autoinflammatory diseases in a pediatric clinical setting: a retrospective analysis.. Pediatric Rheumatology. 2020; 18(1).

DiFrancesco, MW; Lee, G; Altaye, M; Beebe, DW; Meyers-Eaton, J; Brunner, HI. Cerebral microvascular and microstructural integrity is regionally altered in patients with systemic lupus erythematosus.. Arthritis Research and Therapy. 2020; 22(1).

Brunner, HI; Abud-Mendoza, C; Viola, DO; Calvo Penades, I; Levy, D; Anton, J; Calderon, JE; Chasnyk, VG; Ferrandiz, MA; Keltsev, V; Paz Gastanaga, ME; Shishov, M; Boteanu, AL; Henrickson, M; Bass, D; Clark, K; Hammer, A; Ji, BN; Nino, A; Roth, DA; Struemper, H; Wang, M; Martini, A; Lovell, D; Ruperto, N; Paediatric Rheumatology International Trials Organisation (PRINTO); Pediatric Rheumatology Collaborative Study Group (PRINTO). Safety and efficacy of intravenous belimumab in children with systemic lupus erythematosus: results from a randomised, placebo-controlled trial.. Annals of the Rheumatic Diseases. 2020; 79(10):1340-1348.

Henderson, LA; Canna, SW; Friedman, KG; Gorelik, M; Lapidus, SK; Bassiri, H; Behrens, EM; Ferris, A; Kernan, KF; Schulert, GS; Seo, P; F. Son, MB; Tremoulet, AH; Yeung, RS M; Mudano, AS; Turner, AS; Karp, DR; Mehta, JJ. American College of Rheumatology Clinical Guidance for Multisystem Inflammatory Syndrome in Children Associated With SARS-CoV-2 and Hyperinflammation in Pediatric COVID-19: Version 1.. Arthritis and Rheumatology. 2020; 72(11):1791-1805.

Ruperto, N; Brunner, HI; Pacheco-Tena, C; Louw, I; Vega-Cornejo, G; Spindler, AJ; Kingsbury, DJ; Schmeling, H; Borzutzky, A; Cuttica, R; Inman, CJ; Malievskiy, V; Scott, C; Keltsev, V; Terreri, MT; Viola, DO; Xavier, RM; Fernandes, TA P; Velázquez, MD R M; Henrickson, M; Clark, MB; Bensley, KA; Li, X; Lo, KH; Leu, JH; Hsu, C; Hsia, EC; Xu, Z; Martini, A; Lovell, DJ; Pediatric Rheumatology Collaborative Study Group (PRCSG); Paediatric Rheumatology International Trials Organisation (PRINTO). Open-Label Phase 3 Study of Intravenous Golimumab in Patients With Polyarticular Juvenile Idiopathic Arthritis.. Rheumatology. 2021.